Innovation Pharmaceuticals Inc (IPIX)

[attilathehunt]

Merck announced Thursday it will end the development of a Covid-19 drug it acquired from biopharmaceutical company OncoImmune.

Merck disclosed in February that U.S. regulators had asked for more data on the drug to support a potential emergency use authorization.

Due to “regulatory uncertainties” and the time and resources needed to provide the additional data, Merck said it decided to discontinue the development of the drug.


It sure sounds like Merck is eyeing another company that is further along in it's pipeline. You can't tell me they didn't consider it a possibility that time and resources would be required for additional data! They are in the drug business and they deal with the FDA intimately. I think they are moving on to plan B!